Market Research Industry Reports

GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • DESCRIPTION
  • TABLE OF CONTENTS
  • RELATED REPORTS
  • SAMPLE REQUEST
  • REVIEWS
Summary

GeNO LLC (GeNO) is a biopharmaceutical company that offers pulmonary and cardiac disease management solutions. The company offers development of inhaled nitric oxide products for use in hospital setting and for longer-term applications. It provides next-generation drug products which include GeNOsyl Acute DS for use in the hospital setting, and GeNOsyl Chronic DS, a lightweight system that used by patients with chronic diseases. The companys technologies comprise GeNO nitric oxide technology, single-use drug cassette, reactor cartridges, and consoles and controllers. It markets its products across the US. GeNO is headquartered in Cocoa, Florida, the US.

GeNO LLC - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the companys Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the companys financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the companys major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Companys (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the companys operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the companys financial deals that enable you to understand the companys expansion/divestiture and fund requirements
- The profile enables you to analyze the companys financial deals by region, by year, by business segments and by type, for a five year period.

Understand the companys business segments expansion / divestiture strategy
- The profile presents deals from the companys core business segments perspective to help you understand its corporate strategy.

Access elaborate information on the companys recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Companys key financial metrics and ratios.

Equip yourself with detailed information about the companys operations to identify potential customers and suppliers.
- The profile analyzes the companys business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

3
List of Tables 4
List of Figures 4
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO LLC, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
GeNO Raises US$14.7 Million In Venture Financing 11
Equity Offering 12
GeNO Withdraws IPO for USD50 Million 12
Acquisition 13
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC - Key Competitors 14
GeNO LLC - Key Employees 15
GeNO LLC - Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List Of Tables

List of Tables
GeNO LLC, Pharmaceuticals & Healthcare, Key Facts 2
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
GeNO LLC, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
GeNO LLC, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
GeNO LLC, Deals By Therapy Area, 2011 to YTD 2017 8
GeNO LLC, Medical Devices Deals, 2011 to YTD 2017 9
GeNO LLC, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
GeNO Raises US$14.7 Million In Venture Financing 11
GeNO Withdraws IPO for USD50 Million 12
The Medicines Company Acquires Minority Stake In GeNO 13
GeNO LLC, Key Competitors 14
GeNO LLC, Key Employees 15
GeNO LLC, Other Locations 16

Accugenomics Inc - Product Pipeline Analysis, 2018 Update

Accugenomics Inc (Accugenomics) is a developer of oncology molecular diagnostics. The company develops and markets gene expression tests to diagnose and monitor cancer treatment. It offers gene expression tests including

USD 750View Report

Genomic Health Inc (GHDX) - Product Pipeline Analysis, 2018 Update

Genomic Health Inc (Genomic Health) is a provider of genomic-based diagnostic tests and clinical laboratory services for the diagnosis of cancer. The companys commercial product portfolio comprises Onco type DX

USD 750View Report

Ethicon US LLC - Product Pipeline Analysis, 2018 Update

Ethicon US LLC (Ethicon), a subsidiary of Johnson and Johnson, is a medical equipment company which operates through Ethicon Inc, and Ethicon Endo-Surgery Inc. It develops and markets surgical

USD 750View Report

GE Healthcare LLC - Product Pipeline Analysis, 2018 Update

GE Healthcare LLC (GE Healthcare) a business unit of General Electric Company, is a global medical device provider that designs, develops, manufactures, and distributes diagnostic imaging and clinical systems; products

USD 750View Report

Your are not allow to send sample request
Fill The Form For Sample Request
Full Name :*
Bussiness Email: *
Email: *
Country :*
Contact No.*
Alternate No.
Note.:*Kindly provide us with your company id and get the sample reports at the earliest.
There is no Reviews available

Delivery Details

PDF FORMAT REPORTS will be delivered by email within 12 to 24 hours after placing the order (Mon-Fri IST)

CHOOSE FORMAT

  • PDF    USD 250
  • Site Licence    USD 500
  • Enterprise Wide Licence    USD 750
$ 250

Reports Details

Published Date : Oct 2017
No. of Pages :17
Country :United States of America
Category :Pharmaceuticals and Healthcare
Publisher :GlobalData
Report Delivery By :Email
Report Delivery Time :12 to 24 hours after placing the order.

Customized Research

If you do not find this specific report suitable to your exact needs then you can also opt for customized research report that will befit all your expectation. To specify your requirements CLICK HERE

 

We Accept

  • fb
  • twitter
  • pinterest
  • linckedin
  • rss
  • youtube